Key Highlights: 1 March 2024: Suven Pharmaceuticals merger, Vedanta appeal rejected by Supreme Court, Indian Hotel to recruit 2000-2500 employees, DLF to develop 10 million sq. ft in FY25 with revenue of ₹24,200 crore
Suven Pharmaceuticals: Global private equity firm Advent International has merged two of its pharmaceutical portfolio firms, Cohance Lifesciences and Suven Pharmaceuticals, according to a joint announcement. The merged entity will…